Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT)
Klara Kvorning Ternov, Jens Sønksen, Mikkel Fode, Henriette Lindberg, Caroline Kistorp, Rasmus Bisbjerg, Jens Faber, Tobias Wirenfeldt Klausen, Ganesh S. Palapattu, Peter Busch Østergren
Topics & Concepts
Abiraterone acetateEnzalutamideProstate cancerMedicinePrednisoneOncologyInternal medicineQuality of life (healthcare)CastrationRandomized controlled trialClinical trialUrologyCancerAndrogen deprivation therapyHormoneNursingAndrogen receptorProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBone health and treatments